MCID: PDT002
MIFTS: 15

Pediatric Meningioma malady

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Pediatric Meningioma

Aliases & Descriptions for Pediatric Meningioma:

Name: Pediatric Meningioma 12
Childhood Meningioma 69

Classifications:



External Ids:

Disease Ontology 12 DOID:4593
NCIt 47 C8264
UMLS 69 C0280656

Summaries for Pediatric Meningioma

MalaCards based summary : Pediatric Meningioma, also known as childhood meningioma, is related to childhood brain meningioma. The drugs Cisplatin and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include lymph node.

Related Diseases for Pediatric Meningioma

Diseases related to Pediatric Meningioma via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 childhood brain meningioma 10.9

Symptoms & Phenotypes for Pediatric Meningioma

Drugs & Therapeutics for Pediatric Meningioma

Drugs for Pediatric Meningioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 92)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
2
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
3
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
4
Ondansetron Approved Phase 3 99614-02-5 4595
5 Peripheral Nervous System Agents Phase 3,Phase 1
6 Antiemetics Phase 3
7 Autonomic Agents Phase 3
8 BB 1101 Phase 3
9 Dexamethasone 21-phosphate Phase 3
10 Dexamethasone acetate Phase 3 1177-87-3
11 Emetics Phase 3
12 Gastrointestinal Agents Phase 3,Phase 2
13
Carboplatin Approved Phase 1, Phase 2 41575-94-4 10339178 498142 38904
14
Etoposide Approved Phase 1, Phase 2 33419-42-0 36462
15
Dasatinib Approved, Investigational Phase 1, Phase 2 302962-49-8 3062316
16
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
17
Mechlorethamine Approved Phase 1, Phase 2 51-75-2 4033
18
Menthol Approved Phase 2 2216-51-5 16666
19
Octreotide Approved, Investigational Phase 2 83150-76-9 383414 6400441
20
Somatostatin Approved Phase 2 38916-34-6, 51110-01-1 53481605
21
Lapatinib Approved March 2007, Investigational Phase 2 231277-92-2, 388082-78-8 208908 9941095
22 Protein Kinase Inhibitors Phase 2,Phase 1
23 Alkylating Agents Phase 1, Phase 2
24 Antineoplastic Agents, Alkylating Phase 1, Phase 2
25 Antineoplastic Agents, Phytogenic Phase 1, Phase 2
26 Etoposide phosphate Phase 1, Phase 2
27 Liver Extracts Phase 1, Phase 2
28 Topoisomerase Inhibitors Phase 1, Phase 2
29 Isophosphamide mustard Phase 1, Phase 2
30 Antineoplastic Agents, Hormonal Phase 2
31 Edotreotide Phase 2
32 Hormone Antagonists Phase 2
33 Hormones Phase 2
34 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
35 Pharmaceutical Solutions Phase 2
36 Radiopharmaceuticals Phase 2
37 arginine Nutraceutical Phase 2
38 lysine Nutraceutical Phase 2
39
Bortezomib Approved, Investigational Phase 1 179324-69-7 387447 93860
40
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
41
Doxorubicin Approved, Investigational Phase 1 23214-92-8 31703
42
Dacarbazine Approved, Investigational Phase 1 4342-03-4 5351166
43
Lenograstim Approved Phase 1 135968-09-1
44
Temozolomide Approved, Investigational Phase 1 85622-93-1 5394
45
Lenalidomide Approved Phase 1 191732-72-6 216326
46
Romidepsin Approved, Investigational Phase 1 128517-07-7 5352062
47
Busulfan Approved, Investigational Phase 1 55-98-1 2478
48
Palbociclib Approved Phase 1 571190-30-2 11431660 5005498 5330286
49
Trioxsalen Approved Phase 1 3902-71-4 5585
50
Topotecan Approved, Investigational Phase 1 119413-54-6, 123948-87-8 60700

Interventional clinical trials:

(show all 36)
id Name Status NCT ID Phase
1 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Active, not recruiting NCT01346267 Phase 3
2 Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Completed NCT00973739 Phase 2
3 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00006102 Phase 2
4 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2
5 Dosimetry Guided PRRT With 90Y-DOTATOC Not yet recruiting NCT03013387 Phase 2
6 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1
7 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Completed NCT01158300 Phase 1
8 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1
9 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1
10 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1
11 SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors Completed NCT00015899 Phase 1
12 Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma Completed NCT00363272 Phase 1
13 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Completed NCT00053963 Phase 1
14 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1
15 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1
16 VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors Completed NCT00098761 Phase 1
17 Busulfan in Treating Children and Adolescents With Refractory CNS Cancer Completed NCT00006246 Phase 1
18 Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer Completed NCT00053118 Phase 1
19 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy Completed NCT00030108 Phase 1
20 ABT-751 in Treating Young Patients With Refractory Solid Tumors Completed NCT00036959 Phase 1
21 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors Completed NCT00303940 Phase 1
22 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1
23 Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors Completed NCT00503724 Phase 1
24 Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Recruiting NCT02255461 Phase 1
25 Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors Recruiting NCT01682746 Phase 1
26 SU5416 in Treating Children With Recurrent or Progressive Brain Tumors Terminated NCT00006247 Phase 1
27 Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors Terminated NCT00112619 Phase 1
28 MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer Terminated NCT00572182 Phase 1
29 Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer Unknown status NCT00349024
30 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer Completed NCT00002485
31 Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial Completed NCT00890435
32 Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Recruiting NCT00919750
33 Collecting and Storing Tissue From Young Patients With Cancer Recruiting NCT00898755
34 Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain Active, not recruiting NCT00452868
35 Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors Withdrawn NCT00624962
36 Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors Withdrawn NCT00897858

Search NIH Clinical Center for Pediatric Meningioma

Genetic Tests for Pediatric Meningioma

Anatomical Context for Pediatric Meningioma

MalaCards organs/tissues related to Pediatric Meningioma:

39
Lymph Node

Publications for Pediatric Meningioma

Articles related to Pediatric Meningioma:

id Title Authors Year
1
Prediction of pediatric meningioma recurrence by preoperative MRI assessment. ( 27037557 )
2016
2
Pediatric meningioma: current approaches and future direction. ( 21203895 )
2011
3
Aggressive pediatric meningioma with soft tissue and lymph node metastases: a case report. ( 19086745 )
2009
4
Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization. ( 17478763 )
2007

Variations for Pediatric Meningioma

Expression for Pediatric Meningioma

Search GEO for disease gene expression data for Pediatric Meningioma.

Pathways for Pediatric Meningioma

GO Terms for Pediatric Meningioma

Sources for Pediatric Meningioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....